_id
69148631ccc777a4e85d962e
Ticker
OABI
Name
OmniAb Inc.
Exchange
NASDAQ
Address
5980 Horton Street, EmeryVille, CA, United States, 94608
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.omniab.com
Description
OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada. The company's technology platform creates and screens diverse antibody repertoires to identify optimal antibodies and other target-binding proteins for partners' drug development efforts. Its OmniAb platform's Biological Intelligence powers the immune systems of its proprietary and engineered transgenic animals to create optimized antibody candidates for human therapeutics. The company's animal-based technologies include OmniRat, OmniChicken, and OmniMouse, which have been genetically modified to generate antibodies with human sequences; OmniFlic, a bispecific rat and OmniClic, a bispecific chicken are designed for discovery of bispecific antibody applications; OmniTaur, which provides cow-inspired antibodies with unique structural characteristics for challenging targets; OmnidAb, an in vivo platform for the discovery of single-domain antibodies based upon a human VH scaffold; and OmniDeep, a suite of in silico, an artificial intelligence (AI) and machine learning tools for therapeutic discovery and optimization through various technologies and capabilities. The company has an agreement with mAbsolve Ltd. for its Fc-silencing platform technology to incorporate the STR technology into antibodies that have been generated using OmniAb's antibody discovery platform. OmniAb, Inc. was founded in 2012 and is headquartered in Emeryville, California.
Last Close
2.16
Volume
335479
Current Price
2.15
Change
-0.4629629629629736
Last Updated
2025-12-02T12:55:32.309Z
Image
data:image/webp;base64,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
Ipo Date
2022-11-02T00:00:00.000Z
Market Cap
250482384
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.999
Sentiment Sources
1
Rating
4.75
Target Price
7.3333
Strong Buy
6
Buy
2
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
2239000
Cost Of Revenue
4684000
Gross Profit
-2445000
Operating Expenses
15719000
Operating Income
-18164000
Interest Expense
-
Pretax Income
-15364001
Net Income
-16524999
Eps
-0.14403883165106426
Dividends Per Share
-
Shares Outstanding
143955400
Income Tax Expense
1160999
EBITDA
-10709001
Operating Margin
-811.2550245645376
Total Other Income Expense Net
2799999
Cash
28537000
Short Term Investments
30963000
Receivables
3095000
Inventories
443000
Total Current Assets
66349000
Property Plant Equipment
29397000
Total Assets
309690000
Payables
1908000
Short Term Debt
3861000
Long Term Debt
-
Total Liabilities
32246000
Equity
277444000
Depreciation
4655000
Change In Working Capital
-532000
Cash From Operations
-9763000
Capital Expenditures
182000
Cash From Investing
-7665000
Cash From Financing
27684000
Net Change In Cash
10256000
PE
-
PB
0.8890475194994305
ROE
-5.956156557719756
ROA
-5.335980819529206
FCF
-9945000
Fcf Percent
-4.441715051362215
Piotroski FScore
1
Health Score
34
Deep Value Investing Score
5.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
4.5
Net Net Investing Score
2.5
Quality Investing Score
3
Value Investing Score
5.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
2239000
Quarters > 0 > income Statement > cost Of Revenue
4684000
Quarters > 0 > income Statement > gross Profit
-2445000
Quarters > 0 > income Statement > operating Expenses
15719000
Quarters > 0 > income Statement > operating Income
-18164000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-15364001
Quarters > 0 > income Statement > net Income
-16524999
Quarters > 0 > income Statement > eps
-0.14403883165106426
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
114726000
Quarters > 0 > income Statement > income Tax Expense
1160999
Quarters > 0 > income Statement > EBITDA
-10709001
Quarters > 0 > income Statement > operating Margin
-811.2550245645376
Quarters > 0 > income Statement > total Other Income Expense Net
2799999
Quarters > 0 > balance Sheet > cash
28537000
Quarters > 0 > balance Sheet > short Term Investments
30963000
Quarters > 0 > balance Sheet > receivables
3095000
Quarters > 0 > balance Sheet > inventories
443000
Quarters > 0 > balance Sheet > total Current Assets
66349000
Quarters > 0 > balance Sheet > property Plant Equipment
29397000
Quarters > 0 > balance Sheet > total Assets
309690000
Quarters > 0 > balance Sheet > payables
1908000
Quarters > 0 > balance Sheet > short Term Debt
3861000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
32246000
Quarters > 0 > balance Sheet > equity
277444000
Quarters > 0 > cash Flow > net Income
-16524999
Quarters > 0 > cash Flow > depreciation
4655000
Quarters > 0 > cash Flow > change In Working Capital
-532000
Quarters > 0 > cash Flow > cash From Operations
-9763000
Quarters > 0 > cash Flow > capital Expenditures
182000
Quarters > 0 > cash Flow > cash From Investing
-7665000
Quarters > 0 > cash Flow > cash From Financing
27684000
Quarters > 0 > cash Flow > net Change In Cash
10256000
Quarters > 0 > ratios > PE
-0.14403883165106426
Quarters > 0 > ratios > PB
0.8890475194994305
Quarters > 0 > ratios > ROE
-5.956156557719756
Quarters > 0 > ratios > ROA
-5.335980819529206
Quarters > 0 > ratios > FCF
-9945000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-4.441715051362215
Quarters > 0 > health Score
34
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
3897000
Quarters > 1 > income Statement > cost Of Revenue
262000
Quarters > 1 > income Statement > gross Profit
3635000
Quarters > 1 > income Statement > operating Expenses
19854000
Quarters > 1 > income Statement > operating Income
-16219000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-15756000
Quarters > 1 > income Statement > net Income
-15875000
Quarters > 1 > income Statement > eps
-0.14955533783019934
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
106148000
Quarters > 1 > income Statement > income Tax Expense
119000
Quarters > 1 > income Statement > EBITDA
-14570000
Quarters > 1 > income Statement > operating Margin
-416.1919425198871
Quarters > 1 > income Statement > total Other Income Expense Net
463000
Quarters > 1 > balance Sheet > cash
18281000
Quarters > 1 > balance Sheet > short Term Investments
23334000
Quarters > 1 > balance Sheet > receivables
2706000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
47618000
Quarters > 1 > balance Sheet > property Plant Equipment
30746000
Quarters > 1 > balance Sheet > total Assets
295674000
Quarters > 1 > balance Sheet > payables
1977000
Quarters > 1 > balance Sheet > short Term Debt
3844000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
33610000
Quarters > 1 > balance Sheet > equity
262064000
Quarters > 1 > cash Flow > net Income
-15875000
Quarters > 1 > cash Flow > depreciation
4649000
Quarters > 1 > cash Flow > change In Working Capital
3896000
Quarters > 1 > cash Flow > cash From Operations
-5146000
Quarters > 1 > cash Flow > capital Expenditures
165000
Quarters > 1 > cash Flow > cash From Investing
12299000
Quarters > 1 > cash Flow > cash From Financing
236000
Quarters > 1 > cash Flow > net Change In Cash
7389000
Quarters > 1 > ratios > PE
-0.14955533783019934
Quarters > 1 > ratios > PB
0.870849105562
Quarters > 1 > ratios > ROE
-6.057680566579156
Quarters > 1 > ratios > ROA
-5.369088929023181
Quarters > 1 > ratios > FCF
-5311000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-1.3628432127277392
Quarters > 1 > health Score
34
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
4154000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
4154000
Quarters > 2 > income Statement > operating Expenses
22998000
Quarters > 2 > income Statement > operating Income
-18844000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-18306000
Quarters > 2 > income Statement > net Income
-18200000
Quarters > 2 > income Statement > eps
-0.1723125863929863
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
105622000
Quarters > 2 > income Statement > income Tax Expense
-106000
Quarters > 2 > income Statement > EBITDA
-14101000
Quarters > 2 > income Statement > operating Margin
-453.6350505536832
Quarters > 2 > income Statement > total Other Income Expense Net
538000
Quarters > 2 > balance Sheet > cash
10892000
Quarters > 2 > balance Sheet > short Term Investments
32703000
Quarters > 2 > balance Sheet > receivables
6478000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
53578000
Quarters > 2 > balance Sheet > property Plant Equipment
31950000
Quarters > 2 > balance Sheet > total Assets
306182000
Quarters > 2 > balance Sheet > payables
1933000
Quarters > 2 > balance Sheet > short Term Debt
3813000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
32666000
Quarters > 2 > balance Sheet > equity
273516000
Quarters > 2 > cash Flow > net Income
-18200000
Quarters > 2 > cash Flow > depreciation
4743000
Quarters > 2 > cash Flow > change In Working Capital
-5402000
Quarters > 2 > cash Flow > cash From Operations
-15872000
Quarters > 2 > cash Flow > capital Expenditures
209000
Quarters > 2 > cash Flow > cash From Investing
-878000
Quarters > 2 > cash Flow > cash From Financing
44000
Quarters > 2 > cash Flow > net Change In Cash
-16706000
Quarters > 2 > ratios > PE
-0.1723125863929863
Quarters > 2 > ratios > PB
0.8302523435557699
Quarters > 2 > ratios > ROE
-6.65408970590386
Quarters > 2 > ratios > ROA
-5.944176992769007
Quarters > 2 > ratios > FCF
-16081000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-3.8712084737602313
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
10804000
Quarters > 3 > income Statement > cost Of Revenue
11050000
Quarters > 3 > income Statement > gross Profit
10804000
Quarters > 3 > income Statement > operating Expenses
26684000
Quarters > 3 > income Statement > operating Income
-15880000
Quarters > 3 > income Statement > interest Expense
3106000
Quarters > 3 > income Statement > pretax Income
-15223000
Quarters > 3 > income Statement > net Income
-13068000
Quarters > 3 > income Statement > eps
-0.12470060594494012
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
104795000
Quarters > 3 > income Statement > income Tax Expense
-2155000
Quarters > 3 > income Statement > EBITDA
-8274000
Quarters > 3 > income Statement > operating Margin
-146.98259903739356
Quarters > 3 > income Statement > total Other Income Expense Net
657000
Quarters > 3 > balance Sheet > cash
27598000
Quarters > 3 > balance Sheet > short Term Investments
31836000
Quarters > 3 > balance Sheet > receivables
5272000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
68138000
Quarters > 3 > balance Sheet > property Plant Equipment
33281000
Quarters > 3 > balance Sheet > total Assets
325558000
Quarters > 3 > balance Sheet > payables
2297000
Quarters > 3 > balance Sheet > short Term Debt
3782000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
37940000
Quarters > 3 > balance Sheet > equity
287618000
Quarters > 3 > cash Flow > net Income
-13068000
Quarters > 3 > cash Flow > depreciation
7606000
Quarters > 3 > cash Flow > change In Working Capital
-1379000
Quarters > 3 > cash Flow > cash From Operations
-3872000
Quarters > 3 > cash Flow > capital Expenditures
46000
Quarters > 3 > cash Flow > cash From Investing
385000
Quarters > 3 > cash Flow > cash From Financing
3849000
Quarters > 3 > cash Flow > net Change In Cash
362000
Quarters > 3 > ratios > PE
-0.12470060594494012
Quarters > 3 > ratios > PB
0.7833628284738785
Quarters > 3 > ratios > ROE
-4.543526483043482
Quarters > 3 > ratios > ROA
-4.01403129396298
Quarters > 3 > ratios > FCF
-3918000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.3626434653831914
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
26391000
Annuals > 0 > income Statement > cost Of Revenue
19683000
Annuals > 0 > income Statement > gross Profit
26391000
Annuals > 0 > income Statement > operating Expenses
100893000
Annuals > 0 > income Statement > operating Income
-74502000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-71411000
Annuals > 0 > income Statement > net Income
-62033000
Annuals > 0 > income Statement > eps
-0.6059981438968397
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
102365000
Annuals > 0 > income Statement > income Tax Expense
-9378000
Annuals > 0 > income Statement > EBITDA
-50919000
Annuals > 0 > income Statement > operating Margin
-282.30078435830393
Annuals > 0 > income Statement > total Other Income Expense Net
3091000
Annuals > 0 > balance Sheet > cash
27598000
Annuals > 0 > balance Sheet > short Term Investments
31836000
Annuals > 0 > balance Sheet > receivables
5272000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
68138000
Annuals > 0 > balance Sheet > property Plant Equipment
33281000
Annuals > 0 > balance Sheet > total Assets
325558000
Annuals > 0 > balance Sheet > payables
2297000
Annuals > 0 > balance Sheet > short Term Debt
3782000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
37940000
Annuals > 0 > balance Sheet > equity
287618000
Annuals > 0 > cash Flow > net Income
-62033000
Annuals > 0 > cash Flow > depreciation
23583000
Annuals > 0 > cash Flow > change In Working Capital
-10172000
Annuals > 0 > cash Flow > cash From Operations
-39664000
Annuals > 0 > cash Flow > capital Expenditures
1875000
Annuals > 0 > cash Flow > cash From Investing
37884000
Annuals > 0 > cash Flow > cash From Financing
13020000
Annuals > 0 > cash Flow > net Change In Cash
11240000
Annuals > 0 > ratios > PE
-0.6059981438968397
Annuals > 0 > ratios > PB
0.619276609947917
Annuals > 0 > ratios > ROE
-21.567843459032467
Annuals > 0 > ratios > ROA
-19.054362049158673
Annuals > 0 > ratios > FCF
-41539000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-1.5739835549998105
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
34164000
Annuals > 1 > income Statement > cost Of Revenue
19497000
Annuals > 1 > income Statement > gross Profit
34164000
Annuals > 1 > income Statement > operating Expenses
103583000
Annuals > 1 > income Statement > operating Income
-69419000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-64363000
Annuals > 1 > income Statement > net Income
-50619000
Annuals > 1 > income Statement > eps
-0.5077997251286579
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
99683000
Annuals > 1 > income Statement > income Tax Expense
-13744000
Annuals > 1 > income Statement > EBITDA
-49922000
Annuals > 1 > income Statement > operating Margin
-203.19341997424186
Annuals > 1 > income Statement > total Other Income Expense Net
5056000
Annuals > 1 > balance Sheet > cash
16358000
Annuals > 1 > balance Sheet > short Term Investments
70625000
Annuals > 1 > balance Sheet > receivables
3844000
Annuals > 1 > balance Sheet > inventories
1
Annuals > 1 > balance Sheet > total Current Assets
94901000
Annuals > 1 > balance Sheet > property Plant Equipment
38133000
Annuals > 1 > balance Sheet > total Assets
375225000
Annuals > 1 > balance Sheet > payables
4411000
Annuals > 1 > balance Sheet > short Term Debt
3486000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
60640000
Annuals > 1 > balance Sheet > equity
314585000
Annuals > 1 > cash Flow > net Income
-50619000
Annuals > 1 > cash Flow > depreciation
19497000
Annuals > 1 > cash Flow > change In Working Capital
24871000
Annuals > 1 > cash Flow > cash From Operations
2347000
Annuals > 1 > cash Flow > capital Expenditures
1644000
Annuals > 1 > cash Flow > cash From Investing
-18376000
Annuals > 1 > cash Flow > cash From Financing
-892000
Annuals > 1 > cash Flow > net Change In Cash
-16921000
Annuals > 1 > ratios > PE
-0.5077997251286579
Annuals > 1 > ratios > PB
0.551356294801087
Annuals > 1 > ratios > ROE
-16.09072269815789
Annuals > 1 > ratios > ROA
-13.490305816510094
Annuals > 1 > ratios > FCF
703000
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
0.020577215782695234
Annuals > 1 > health Score
35
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
59077000
Annuals > 2 > income Statement > cost Of Revenue
16250000
Annuals > 2 > income Statement > gross Profit
59077000
Annuals > 2 > income Statement > operating Expenses
85725000
Annuals > 2 > income Statement > operating Income
-26648000
Annuals > 2 > income Statement > interest Expense
587000
Annuals > 2 > income Statement > pretax Income
-26061000
Annuals > 2 > income Statement > net Income
-22334000
Annuals > 2 > income Statement > eps
-0.2617735999437399
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
85318000
Annuals > 2 > income Statement > income Tax Expense
-3727000
Annuals > 2 > income Statement > EBITDA
-8399000
Annuals > 2 > income Statement > operating Margin
-45.107232933290454
Annuals > 2 > income Statement > total Other Income Expense Net
587000
Annuals > 2 > balance Sheet > cash
33390000
Annuals > 2 > balance Sheet > short Term Investments
54875000
Annuals > 2 > balance Sheet > receivables
30290000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
124950000
Annuals > 2 > balance Sheet > property Plant Equipment
41462000
Annuals > 2 > balance Sheet > total Assets
421212000
Annuals > 2 > balance Sheet > payables
2971000
Annuals > 2 > balance Sheet > short Term Debt
1780000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
79839000
Annuals > 2 > balance Sheet > equity
341373000
Annuals > 2 > cash Flow > net Income
-22334000
Annuals > 2 > cash Flow > depreciation
18249000
Annuals > 2 > cash Flow > change In Working Capital
-10833000
Annuals > 2 > cash Flow > cash From Operations
-3587000
Annuals > 2 > cash Flow > capital Expenditures
17168000
Annuals > 2 > cash Flow > cash From Investing
-73313000
Annuals > 2 > cash Flow > cash From Financing
110739000
Annuals > 2 > cash Flow > net Change In Cash
33839000
Annuals > 2 > ratios > PE
-0.2617735999437399
Annuals > 2 > ratios > PB
0.43487129913613554
Annuals > 2 > ratios > ROE
-6.542403763625125
Annuals > 2 > ratios > ROA
-5.302318072609517
Annuals > 2 > ratios > FCF
-20755000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-0.35132115713391
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
34748000
Annuals > 3 > income Statement > cost Of Revenue
14968000
Annuals > 3 > income Statement > gross Profit
34748000
Annuals > 3 > income Statement > operating Expenses
70357000
Annuals > 3 > income Statement > operating Income
-35609000
Annuals > 3 > income Statement > interest Expense
7000
Annuals > 3 > income Statement > pretax Income
-34350000
Annuals > 3 > income Statement > net Income
-27042000
Annuals > 3 > income Statement > eps
-0.23551469859670707
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
114820859
Annuals > 3 > income Statement > income Tax Expense
-7308000
Annuals > 3 > income Statement > EBITDA
-18091000
Annuals > 3 > income Statement > operating Margin
-102.477840451249
Annuals > 3 > income Statement > total Other Income Expense Net
1259000
Annuals > 3 > balance Sheet > cash
-13851000
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
21136000
Annuals > 3 > balance Sheet > inventories
13851000
Annuals > 3 > balance Sheet > total Current Assets
22542000
Annuals > 3 > balance Sheet > property Plant Equipment
20127000
Annuals > 3 > balance Sheet > total Assets
304465000
Annuals > 3 > balance Sheet > payables
2924000
Annuals > 3 > balance Sheet > short Term Debt
578000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
70158000
Annuals > 3 > balance Sheet > equity
234307000
Annuals > 3 > cash Flow > net Income
-27042000
Annuals > 3 > cash Flow > depreciation
16252000
Annuals > 3 > cash Flow > change In Working Capital
-2631000
Annuals > 3 > cash Flow > cash From Operations
-5672000
Annuals > 3 > cash Flow > capital Expenditures
4070000
Annuals > 3 > cash Flow > cash From Investing
-4025000
Annuals > 3 > cash Flow > cash From Financing
9697000
Annuals > 3 > cash Flow > net Change In Cash
9697000
Annuals > 3 > ratios > PE
-0.23551469859670707
Annuals > 3 > ratios > PB
0.8526774473660624
Annuals > 3 > ratios > ROE
-11.541268506702744
Annuals > 3 > ratios > ROA
-8.881809074934722
Annuals > 3 > ratios > FCF
-9742000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-0.2803614596523541
Annuals > 3 > health Score
34
Valuation > metrics > PE
-0.14403883165106426
Valuation > metrics > PB
0.8890475194994305
Valuation > final Score
70
Valuation > verdict
11.1% Undervalued
Profitability > metrics > ROE
-5.956156557719756
Profitability > metrics > ROA
-24.90617643069225
Profitability > metrics > Net Margin
-7.3805265743635555
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.11622525626793155
Risk > metrics > Interest Coverage
-3.9020408163265308
Risk > final Score
44
Risk > verdict
High
Liquidity > metrics > Current Ratio
11.500953371468192
Liquidity > metrics > Quick Ratio
11.424163633211995
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
5
Prev Risks > 1
42
Prev Risks > 2
40
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T00:57:15.047Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-05
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.14
Earnings History > 0 > eps Estimate
-0.136
Earnings History > 0 > eps Difference
-0.004
Earnings History > 0 > surprise Percent
-2.9412
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-06
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.15
Earnings History > 1 > eps Estimate
-0.13
Earnings History > 1 > eps Difference
-0.02
Earnings History > 1 > surprise Percent
-15.3846
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-07
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.17
Earnings History > 2 > eps Estimate
-0.1667
Earnings History > 2 > eps Difference
-0.0033
Earnings History > 2 > surprise Percent
-1.9796
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-18
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.12
Earnings History > 3 > eps Estimate
-0.0967
Earnings History > 3 > eps Difference
-0.0233
Earnings History > 3 > surprise Percent
-24.0951
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-12
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.16
Earnings History > 4 > eps Estimate
-0.14
Earnings History > 4 > eps Difference
-0.02
Earnings History > 4 > surprise Percent
-14.2857
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-08
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.13
Earnings History > 5 > eps Estimate
-0.17
Earnings History > 5 > eps Difference
0.04
Earnings History > 5 > surprise Percent
23.5294
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-09
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.19
Earnings History > 6 > eps Estimate
-0.16
Earnings History > 6 > eps Difference
-0.03
Earnings History > 6 > surprise Percent
-18.75
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-20
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.14
Earnings History > 7 > eps Estimate
-0.15
Earnings History > 7 > eps Difference
0.01
Earnings History > 7 > surprise Percent
6.6667
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-09
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.16
Earnings History > 8 > eps Estimate
-0.14
Earnings History > 8 > eps Difference
-0.02
Earnings History > 8 > surprise Percent
-14.2857
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-10
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.15
Earnings History > 9 > eps Estimate
-0.12
Earnings History > 9 > eps Difference
-0.03
Earnings History > 9 > surprise Percent
-25
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-11
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.08
Earnings History > 10 > eps Estimate
-0.03
Earnings History > 10 > eps Difference
-0.05
Earnings History > 10 > surprise Percent
-166.6667
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-30
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
0.07
Earnings History > 11 > eps Estimate
0.02
Earnings History > 11 > eps Difference
0.05
Earnings History > 11 > surprise Percent
250
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-10
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.09
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.09
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-12
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.06
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-20
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.16
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-28
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.01
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-10
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.01
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-09-23
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
0
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-06-17
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
0
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada. The company's technology platform creates and screens diverse antibody repertoires to identify optimal antibodies and other target-binding proteins for partners' drug development efforts. Its OmniAb platform's Biological Intelligence powers the immune systems of its proprietary and engineered transgenic animals to create optimized antibody candidates for human therapeutics. The company's animal-based technologies include OmniRat, OmniChicken, and OmniMouse, which have been genetically modified to generate antibodies with human sequences; OmniFlic, a bispecific rat and OmniClic, a bispecific chicken are designed for discovery of bispecific antibody applications; OmniTaur, which provides cow-inspired antibodies with unique structural characteristics for challenging targets; OmnidAb, an in vivo platform for the discovery of single-domain antibodies based upon a human VH scaffold; and OmniDeep, a suite of in silico, an artificial intelligence (AI) and machine learning tools for therapeutic discovery and optimization through various technologies and capabilities. The company has an agreement with mAbsolve Ltd. for its Fc-silencing platform technology to incorporate the STR technology into antibodies that have been generated using OmniAb's antibody discovery platform. OmniAb, Inc. was founded in 2012 and is headquartered in Emeryville, California.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AOmniAb (NASDAQ: OABI) debuts OmniUltra chicken platform for ultralong CDRH3 Stock Titan
Read more →OmniAb Insiders Enjoying US$277k Appreciation On US$1.59m Investment simplywall.st
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$7.3333
Analyst Picks
Strong Buy
6
Buy
2
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 42.42% of the total shares of OmniAb Inc.
1.
Whitefort Capital Management, LP.(7.1134%)
since
2025/06/30
2.
BlackRock Inc(4.8634%)
since
2025/06/30
3.
Vanguard Group Inc(3.6597%)
since
2025/06/30
4.
Dimensional Fund Advisors, Inc.(2.0241%)
since
2025/06/30
5.
Rice Hall James & Associates, LLC(1.825%)
since
2025/06/30
6.
Vanguard Total Stock Mkt Idx Inv(1.7959%)
since
2025/07/31
7.
Private Management Group Inc(1.777%)
since
2025/06/30
8.
Geode Capital Management, LLC(1.6946%)
since
2025/06/30
9.
iShares Russell 2000 ETF(1.6256%)
since
2025/08/31
10.
Citadel Advisors Llc(1.4814%)
since
2025/06/30
11.
State Street Corp(1.3969%)
since
2025/06/30
12.
Kent Lake PR LLC(1.2157%)
since
2025/06/30
13.
Jacobs Levy Equity Management, Inc.(0.768%)
since
2025/06/30
14.
Vanguard Institutional Extnd Mkt Idx Tr(0.7602%)
since
2025/07/31
15.
Fidelity Small Cap Index(0.6965%)
since
2025/06/30
16.
Royce & Associates, LP(0.6023%)
since
2025/06/30
17.
Royce Micro Cap Trust(0.6023%)
since
2025/06/30
18.
Northern Trust Corp(0.5813%)
since
2025/06/30
19.
Charles Schwab Investment Management Inc(0.5781%)
since
2025/06/30
20.
Towerview LLC(0.5773%)
since
2025/06/30
21.
JPMorgan Chase & Co(0.5514%)
since
2025/06/30
22.
Morgan Stanley - Brokerage Accounts(0.5332%)
since
2025/06/30
23.
iShares Russell 2000 Value ETF(0.515%)
since
2025/08/31
24.
Renaissance Technologies Corp(0.4915%)
since
2025/06/30
25.
Millennium Management LLC(0.4517%)
since
2025/06/30
26.
Woodstock Corp(0.4319%)
since
2025/06/30
27.
CREF Stock R3(0.4099%)
since
2025/07/31
28.
Fidelity Extended Market Index(0.3664%)
since
2025/07/31
29.
Vanguard Russell 2000 ETF(0.3332%)
since
2025/07/31
30.
Schwab US Small-Cap ETFâ„¢(0.3258%)
since
2025/08/30
31.
Isthmus Small Cap Core Equity(0.3018%)
since
2025/06/30
32.
Dimensional US Targeted Value ETF(0.2783%)
since
2025/08/29
33.
DFA US Micro Cap I(0.2763%)
since
2025/07/31
34.
DFA US Small Cap I(0.2762%)
since
2025/07/31
35.
DFA US Targeted Value I(0.2617%)
since
2025/07/31
36.
State St Russell Sm Cap® Indx SL Cl I(0.2185%)
since
2025/08/31
37.
Multi-Manager Small Cap Eq Strat Inst(0.1995%)
since
2025/07/31
38.
Omnis US Smaller Companies A Inc(0.1958%)
since
2025/05/31
39.
Vanguard Health Care ETF(0.1878%)
since
2025/07/31
40.
Schwab Small Cap Index(0.1778%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.14
EPS Estimate
-0.136
EPS Difference
-0.004
Surprise Percent
-2.9412%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.